Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but they are unusual In this particular malignancy compared to other lymphoid neoplasms. CHD2 102 However, several teams are advocating for that incorporation of novel markers, for instance a intricate karyotype55 or epigenetic subsets, 27,28 into clinical https://terryy110tlc1.blognody.com/profile